Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference
Editas Medicine, a gene editing company focused on developing transformative in vivo medicines, updated the timing of its presentation at the 2026 Jefferies Global Healthcare Conference to 2:00 p.m. ET on June 4, 2026. The event will be webcast and archived on the company's website.